Abnormal Circulating Pancreatic Enzyme Activities in More than Twenty-Five Percent of Recent-Onset Insulin-Dependent Diabetic Patients: Association of Hyperlipasemia with High-Titer Islet Cell Antibodies

Pancreas

Volumn 12, Issue 4, 1996, Pages 321-333

  Semakula, Crispin ^a   Vandewalle, Christina L ^a   Van Schravendijk, Christiaan F H ^a   Sodoyez, Jean Claude ^d   Schuit, Frans C ^a   Foriers, André ^b   Falorni, Alberto ^e   Craen, Margarita ^f   Decraene, Paul ^g,h   Pipeleers, Daniel G ^a   Gorus, Frans K ^a   Balasse, Edmond ^c,h   Becq, Herman ^c,h   Beirinckx, Joris ^c,h   Bodson, André ^c,h   Coeckelberghs, Marina ^c,h   Coolens, Jean Luc ^c,h   Coucke, Willy ^c,h   Couturier, Etienne ^c,h   Craen, Rita ^c,h   Daubresse, Jean Claude ^c,h   De Cock, Jacques ^c,h   Defoer, Francine ^c,h   De Leeuw, Ivo ^c,h   Delvigne, Colette ^c,h   more..

^a DIABETES RESEARCH CENTER   (Belgium)

^b PHARMACEUTICAL INSTITUTE   (Belgium)

^c BDR   (Belgium)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e KAROLINSKA INSTITUTE   (Sweden)

^f GHENT UNIVERSITY HOSPITAL   (Belgium)

^g IMELDA HOSPITAL   (Belgium)

^h NONE

Author keywords

Glucagon autoantibodies; Glutamic acid decarboxylase autoantibodies; IgM; Insulin autoantibodies; Islet cell cytoplasmic autoantibodies; Pancreatic lipase

Indexed keywords

AMYLASE; GLUCAGON ANTIBODY; INSULIN ANTIBODY; PANCREAS ENZYME; TRIACYLGLYCEROL LIPASE;

ADULT; AGED; ANTIBODY TITER; ARTICLE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EXOCRINE CELL; FEMALE; GENETIC MARKER; GENETIC PREDISPOSITION; HUMAN; HYPERAMYLASEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PANCREAS ISLET CELL; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE FACTORS; AMYLASES; ANALYSIS OF VARIANCE; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCAGON; GLUTAMATE DECARBOXYLASE; HUMANS; INFANT; INFANT, NEWBORN; INSULIN; ISLETS OF LANGERHANS; ISOAMYLASE; LIPASE; MALE; PANCREAS;

EID: 0029986819     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199605000-00001     Document Type: Article

References (73)

1. Henderson JF, Daniel PM, Fraser PA. The pancreas as a single organ: the influence of the endocrine upon exocrine part of the gland [Review]. Gut 1981;22:158-67.
2. Anonymous. Pancreatic islet-acinar interactions [editorial]. Br Med J 1981;283:570-1.
3. Trimble ER, Bruzzone R, Gjinovci A, Renold AE. Activity of the insulo-acinar axis in the isolated perfused pancreas. Endocrinology 1985;117:1246-52.
4. Bendayan M. Contacts between endocrine and exocrine cells in the pancreas. Cell Tissue Res 1982;222:227-30.
5. Matsushita K, Okabayashi Y, Koide M, Hasegawa H, Otsuki M, Kasuga M. Potentiating effect of insulin on exocrine secretory function in isolated rat pancreatic acini. Gastroenterology 1994;106:200-6.
6. Johnsson TM, Rosenberg MP, Meisler MH. An insulin-responsive element in the pancreatic enhancer of the amylase gene. J Biol Chem 1993;268:464-8.
7. Ebert R, Creutzfeldt W. Reversal of impaired GIP and insulin secretion in patients with pancreatigenic steatorrhea following enzyme substitution. Diabetologia 1980;19:198-204.
8. Marks V. The enteroinsular axis [review]. J Clin Pathol 1980;33(S8):38-42.
9. Ludvigsson J, Forsberg P, Frydén A, Lindblom B, Marshall MO, von Schenk H. Mumps with laboratory signs of subclinical pancreatitis may cause a disturbed beta-cell function. Diabetes Res 1988;9:193-5.
10. Lanng S, Thorsteinsson B, Lund-Andersen C, Nerup J, Schiøtz PO, Koch C. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late complications. Acta Paediatr 1994;82:72-7.
11. Klöppel G, Bommer G, Commandeur G, Heitz P. The endocrine pancreas in chronic pancreatitis. Virchows Arch (Pathol Anat) 1978;377:157-74.
12. Lampeter EH, Seifen I, Hohman D, et al. Inflammatory islet damage in patients bearing HLA-DR3 and/or DR4 haplotypes does not lead to islet autoimmunity. Diabetologia 1994;37:471-5.
13. Dandona P, Freedman DB, Foo Y, et al. Exocrine pancreatic function in diabetes mellitus. J Clin Pathol 1984;37: 302-6.
14. Söling HB, Unger KU. The role of insulin in regulation of α-amylase synthesis in the rat pancreas. Eur J Clin Invest 1972;2:199-212.
15. Domsche W, Tympner F, Domsche S, Demling L. Exocrine pancreatic function in juvenile diabetics. Dig Dis 1975;20: 309-12.
16. Sato M, Yamamoto K, Mayama H, Yamashiro Y. Exocrine pancreatic function in diabetic children. J Pediatr Gastroenterol Nutr 1984;3:415-20.
17. Anonymous. Pancreatic abnormalities in type 2 diabetes mellitus [editorial]. Lancet 1987;2:1497-8.
18. Fonseca V, Berger LA, Becket AG, Dandona P. Size of pancreas in diabetes mellitus: a study based on ultrasound. Br Med J 1985;291:1240-1.
19. Yajnik CS, Sahasrabudhe RA, Naik SS, et al. Exocrine pancreatic function (serum immunoreactive trypsin, fecal chymotrypsin and pancreatic isoamylase) in Indian diabetics. Pancreas 1990;5:631-8.
20. Trimble ER. Bruzzone R, Belin D. Insulin resistance is accompanied by impairment of amylase gene expression in the exocrine pancreas of the obese Zucker rat. Biochem J 1986; 257:807-12.
21. Markholst H, Verstergaard Laursen H. Decreased levels of serum α-isoamylase prior to diabetes onset in BB rats. Pancreas 1990;5:144-50.
22. Junglee D, De Albarran R, Katrak A, Freedman DB, Beckett AG, Dandona P. Low pancreatic lipase in insulin-dependent diabetics. J Clin Pathol 1983;36:200-2.
23. Landin-Olsson M, Borgström A, Blom L, Sundkvist G, Lernmark Å, the Swedish Childhood Diabetes Group. Immunoreactive trypsin(ogen) in the sera of children with recent-onset insulin-dependent diabetes and matched controls. Pancreas 1990;3:241-7.
24. Foulis AK, Stewart JA. The pancreas in recent-onset Type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia 1984;26:456-61.
25. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes. Diabetes 1965;14:619-33.
26. Pipeleers D, Ling Z. Pancreatic beta cells in insulin-dependent diabetes [review]. Diabetes Metab Rev 1992;8: 209-27.
27. Klöppel G, Drenck CR, Oberholzer M, Heitz PU. Morphometric evidence for striking B-cell reduction at the clinical onset of type 1 diabetes. Virchows Arch (Pathol Anat) 1984; 403:441-52.
28. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS. The histopathology of the pancreas in Type 1 (insulin-dependent) diabetes mellitus: a 25 year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 1986;29:267-74.
29. Bach J-F. Insulin-dependent diabetes mellitus as an autoimmune disease (review). Endocr Rev 1994;15:516-42.
30. Foulis AK, Francis ND, Farquharson MA, Boylston A. Massive synchronous B-cell necrosis causing type 1 (insulin-dependent) diabetes - a unique histopathological case report. Diabetologia 1988;31:46-50.
31. Kimura N, Fujiya H, Yamaguchi K, Takahaski T, Nagura H. Vanished islets with pancreatitis in acute-onset insulin-dependent diabetes mellitus in an adult. Arch Pathol Lab Med 1994;118:84-8.
32. Nakanishi K, Kobayashi T, Sugimoto T, Murase T, Itoh T, Kinori K. Does pan-pancreatic involvement occur in IDDM [letter]? Diabetes Care 1988;11:100-1.
33. Gorus FK, Anselmo J, Keymeulen B, Type 1 (insulin-dependent) diabetes mellitus: an autoimmune, predictable and preventable disease? Lessons from national registries and new challenges to clinical biology [review]. Acta Clin Belg 1993;48:96-108.
34. Krolewski AS, Warram JH, Rand LI, Kahn CR. Epidemiologic approach to the etiology of type 1 diabetes mellitus and its complications [review]. N Engl J Med 1987;317:1390-8.
35. Caillat-Zucman S, Garchon HY, Timsit J, et al. Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest 1992;90:2241-50.
36. Karjalainen J, Salmela P, Ilonen J, Surcel HM, Knip M. A comparison of childhood and adult type 1 diabetes mellitus. N Engl J Med 1989;320:881-6.
37. Vandewalle CL, Decraene T, Schuit FC, et al. Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB1*0302 haplotype at clinical onset of type 1 (insulin-dependent) diabetes before age 10 years, but not at onset between age 10 and 40 years. Diabetologia 1993;36:1155-62.
38. Decraene T, Vandewalle C, Pipeleers DG, Gorus FK, the Belgian Diabetes Registry. Increased total IgM-levels at clinical onset of type 1 (insulin-dependent) diabetes. Correlation with IgM-binding to cells. Clin Chem 1992;38:1762-7.
39. Vandewalle CL, Falorni A, Svanholm S, Lernmark Å, Pipeleers DG, Gorus FK, the Belgian Diabetes Registry. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in IDDM with clinical onset between age 20 and 40 years. J Clin Endocrinol Metab 1995;80:846-51.
40. Bottazzo GF, Lendrum R. Separate autoantibodies to pancreatic glucagon and somatostatin cells. Lancet 1976;2: 873-6.
41. Schopfer K, Matter L, Tenschert R. Anti-glucagon-cell and anti-adrenal-medullary-cell antibodies in islet-cell-autoantibody-positive diabetic children. N Engl J Med 1984; 310:1536-7.
42. Di Mario U, Anastasi E, Mariani P, et al. Diabetes-related autoantibodies do appear in children with coeliac disease. Acta Paediatr 1992;81:593-7.
43. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
44. Gorus FK, Vandewalle CL, Dorchy H, Van Crombrugge P, Schuit FC, Pipeleers DG, the Belgian Diabetes Registry. Influence of age on the associations among insulin autoantibodies, islet cell antibodies and HLA DQA1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. J Clin Endocrinol Metab 1994; 78:1172-8.
45. Van Hoof V, Geeraerts L, Van Meirvenne H, et al. Reference values for amylase and isoamylases determined by agarose electrophoresis [technical brief]. Clin Chem 1990;36: 1251-2.
46. Gorus FK, Sodoyez JC, Pipeleers DG, et al. Detection of autoantibodies against islet amyloid polypeptide in human serum. Lack of association with type 1 (insulin-dependent) diabetes mellitus, or with conditions favouring amyloid deposition in islets. Diabetologia 1992;35:1080-6.
47. Sinn HJ. Radio iodination of proteins and lipoproteins using N-bromosuccinimide as oxidizing agent. Anal Biochem 1988;170:186-92.
48. Markussen J, Larsen UD. The application of HPLC to the analysis of radio-iodinated tracers of glucagon and insulin. In: Brandenbrug D, Wolmer A, eds. Chemistry, structure and function of insulin and related hormones. Berlin: Walter de Gruyter, 1980:161-8.
49. Van Schravendijk C, Foriers A, Hooghe-Peters E, et al. Pancreatic hormone receptors on islet cells. Endocrinology 1985;117:841-8.
50. Linger RH, Orci L. Glucagon in diabetes mellitus. In: Lefèbvre PJ, ed. Glucagon II. Berlin/Heidelberg: Springer-Verlag, 1983:431-50.
51. Pipeleers DG, Schuit FC, Van Schravendijk CFH, Van De Winkel M. Interplay of nutrients and hormones in the regulation of glucagon release. Endocrinology 1985;117:817-23.
52. Heimberg H, Nagy ZP, Somers G, De Leeuw I, Schuit F. Complementation of HLA DQA and DQB genes confers susceptibility and protection to insulin-dependent diabetes mellitus. Hum Immunol 1992;33:10-7.
53. Bodmer JG, March SGE, Albert ED, et al. Nomenclature for factors of the HLA system: 1994. Hum Immunol 1994;41:1-20.
54. Altman DG. Relation between several variables. In: Practical statistics for medical research. London: Chapman and Hall, 1991:325-64.
55. Norusis MJ. SPSS for windows base system user's guide. Release 6.0. Chicago: SPSS, 1993.
56. Lott JA, Patel SI, Sawhney AK, Kazmierczak SC, Love JE Jr. Assays of serum lipase: analytical and clinical considerations. Clin Chem 1986;32:1290-302.
57. Rosenblum JL. Serum lipase activity is increased in disease states other than acute pancreatitis: amylase revised [editorial]. Clin Chem 1991;37:315-6.
58. Lott JA, Lu CJ. Lipase isoforms and amylase isoenzymes: assays and application in the diagnosis of acute pancreatitis. Clin Chem 1991;37:361-8.
59. Tetrault GA. Lipase activity in serum measured with Ektachem is often increased in non-pancreatic disorders. Clin Chem 1991;37:447-51.
60. Demanet C, Goedhuys W, Haentjes M, Huyghens L, Blaton V, Gorus F. Two automated fully enzymatic assays for lipase activity in serum compared: positive interference from post-heparin lipase activity. Clin Chem 1992;38:288-92.
61. Tietz NW, Sheey DF. Lipase in serum-the elusive enzyme: an overview [review]. Clin Chem 1993;39:746-56.
62. Lessinger JM, Férard G. Plasma pancreatic lipase activity: from analytical specificity to clinical efficiency for the diagnosis of acute pancreatitis. Eur J Clin Chem Clin Biochem 1994;32:377-81.
63. Bossuyt PJ, Van Den Bogaert R, Schärpe SL, Van Maercke Y. Relation of age to isoenzyme pattern and total activity of amylase in serum. Clin Chem 1981;27:451-4.
64. Kurins Gillard B, Simbala JA, Goodglick L. Reference intervals for amylase isoenzymes in serum and plasma of infants and children. Clin Chem 1983;29:1119-23.
65. Meites S, ed. Pediatric clinical chemistry. Reference (normal) values, 3rd ed. Washington, DC: AACC Press, 1989:185-7.
66. Bonner-Weir S, Orci L. New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 1982; 31:883-9.
67. Markholst H, Lernmark Å. Reduced pancreatic insulin is associated with retarded growth of the pancreas in young prediabetic BB rats. Pancreas 1988;3:140-4.
68. Williams A, Goldfine ID. The insulin-pancreatic axis [review]. Diabetes 1985;34:980-6.
69. Jonsson J, Carlssson L, Edlund T, Edlund H. Insulin-promotor factor 1 is required for pancreas development in mice. Nature 1994;37:606-9.
70. Dyck WP, Texter EC, Lasater JM, Hightower NC. Influence of glucagon on pancreatic exocrine function in man. Gastroenterology 1970;58:532-9.
71. Yoon Y, Austin M, Ondera T, Notkins AL. Virus-induced diabetes mellitus. N Engl J Med 1979;300:1173-9.
72. Steinberg W, Tenner S. Acute pancreatitis [review]. N Engl J Med 1994;330:1198-210.
73. Conrad B, Weidmann E, Trucco G, et al. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 1994;371:351-5.